Announcements

Closure of Trading window 

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Corporate presentation for roadshow

Investment in LLP

Meeting with Investors/Analysts

Schedule Of Analysts/Institutional Investor Meet/Con. Call

Intimation of Board Meeting to be held on Friday 11, November , 2022 inter alia, to consider and approve the unaudited Financial results (both Stand-alone  and Consolidated) for the quarter / half year ended September 30, 2022.

Intimation that Trading Window shall remain closed for Directors / Designated Employees / Connected Persons with effect from 01 October 2022, and would be re-opened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter  / Half Year ended September 30, 2022.

Schedule Of Analysts/Institutional Investor Meet/Con. Call

Intimation of allotment of 26,711 Equity Shares pursuant to exercise of ESOPs under ESOP Scheme 2019 

Schedule Of Analysts/Institutional Investor Meet/Con. Call

Transcript of Earnings Call held on 02-08-2022

22^nd Annual General Meeting – Proceedings.

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing copies of newspaper advertisement of unaudited financial results for the Quarter ended 30^th June 2022, published in Free Press Journal (English) and Pudhari (Marathi) in the prescribed format.

Presentation on Audited Financial Results for the quarter ended June 30, 2022.

Intimation of decision taken at the Board Meeting held on August 01, 2022- (i) approval of the Unaudited Financial Results (both Stand-alone and Consolidated) for the quarter ended June 30, 2022

Intimation about conference call for Indian and Overseas Investors to be held on Tuesday, August 02, 2022  to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter ended June 30, 2022. Click here to see the invite

Intimation of Board Meeting to be held on Monday 01, August, 2022 inter alia, to consider and approve the unaudited Financial results (both Stand-alone  and Consolidated) for the quarter ended June 30, 2022.

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the copy of the newspaper advertisement published in Free Press Journal (English) and Pudari (Marathi)

Pursuant to the provisions of Section 91 of the Act, the Register of Members and Share Transfer Books of the Company will remain closed from Wednesday, July 27, 2022 to, August 03, 2022 (both days inclusive) in connection with the AGM

Intimation about 22nd   Annual General Meeting will be on Wednesday, August 03, 2022 at 4.00 P.M. at the Corporate office of the Company situated at D-37/3, TTC, Industrial Area, MIDC, Turbhe, Navi Mumbai-400073.

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from July 01, 2022, and would be re-opened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the quarter ended June 30, 2022

Transcript of Earnings Call held on 06-05-2022

Mr. Rahul Guha has taken charge as the Managing Director & Chief Executive Officer with effect from Wednesday, May 04, 2022. Mr. Rahul Guha will also function as the Managing Director & CEO of Nueclear Healthcare Limited, our wholly owned subsidiary. Mr. Dharmil Sheth, who was appointed as the Managing Director for the interim period to comply with the provisions of Sec. 203 (4) of the Companies Act, 2013, has demitted office effective from Wednesday, May 04, 2022 and will continue to be a Non-Executive, Non-Independent Director of the Company.Intimation